| International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ... The lancet oncology 15 (12), e538-e548, 2014 | 5122 | 2014 |
| Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients C Blimark, E Holmberg, UH Mellqvist, O Landgren, M Björkholm, ... haematologica 100 (1), 107, 2015 | 527 | 2015 |
| Racial disparities in incidence and outcome in multiple myeloma: a population-based study AJ Waxman, PJ Mink, SS Devesa, WF Anderson, BM Weiss, ... Blood, The Journal of the American Society of Hematology 116 (25), 5501-5506, 2010 | 455 | 2010 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 443 | 2016 |
| Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003 SY Kristinsson, O Landgren, PW Dickman, AR Derolf, M Bjorkholm Journal of clinical oncology 25 (15), 1993-1999, 2007 | 404 | 2007 |
| Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up SY Kristinsson, G Gridley, RN Hoover, D Check, O Landgren haematologica 99 (2), 392, 2014 | 343 | 2014 |
| Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes SY Kristinsson, M Björkholm, M Hultcrantz, ÅR Derolf, O Landgren, ... Journal of Clinical Oncology 29 (21), 2897-2903, 2011 | 325 | 2011 |
| Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in … O Landgren, LR Goldin, SY Kristinsson, EA Helgadottir, J Samuelsson, ... Blood, The Journal of the American Society of Hematology 112 (6), 2199-2204, 2008 | 308 | 2008 |
| Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ... Leukemia 30 (5), 1005-1017, 2016 | 292 | 2016 |
| Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms M Björkholm, ÅR Derolf, M Hultcrantz, SY Kristinsson, C Ekstrand, ... Journal of clinical oncology 29 (17), 2410-2415, 2011 | 292 | 2011 |
| Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study SY Kristinsson, RM Pfeiffer, M Björkholm, LR Goldin, S Schulman, ... Blood, The Journal of the American Society of Hematology 115 (24), 4991-4998, 2010 | 280 | 2010 |
| Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel J Caers, B Paiva, E Zamagni, X Leleu, J Bladé, SY Kristinsson, ... Journal of hematology & oncology 11, 1-10, 2018 | 271 | 2018 |
| Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies N Korde, SY Kristinsson, O Landgren Blood, the Journal of the American Society of Hematology 117 (21), 5573-5581, 2011 | 269 | 2011 |
| Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008 M Björkholm, L Ohm, S Eloranta, Å Derolf, M Hultcrantz, J Sjöberg, ... Journal of Clinical Oncology 29 (18), 2514-2520, 2011 | 252 | 2011 |
| Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study M Hultcrantz, M Björkholm, PW Dickman, O Landgren, ÅR Derolf, ... Annals of internal medicine 168 (5), 317-325, 2018 | 243 | 2018 |
| Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study M Hultcrantz, SY Kristinsson, TML Andersson, O Landgren, S Eloranta, ... Journal of clinical oncology 30 (24), 2995-3001, 2012 | 239 | 2012 |
| Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS) S Mailankody, RM Pfeiffer, SY Kristinsson, N Korde, M Bjorkholm, ... Blood, The Journal of the American Society of Hematology 118 (15), 4086-4092, 2011 | 237 | 2011 |
| Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study I Turesson, R Velez, SY Kristinsson, O Landgren Journal of Clinical Oncology 28 (5), 830-834, 2010 | 232 | 2010 |
| Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma SY Kristinsson, TR Fears, G Gridley, I Turesson, UH Mellqvist, ... Blood, The Journal of the American Society of Hematology 112 (9), 3582-3586, 2008 | 219 | 2008 |
| Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ... The Lancet Oncology 22 (3), e105-e118, 2021 | 209 | 2021 |
Ola Landgren在 miami.edu 的电子邮件经过验证
